TABLE 3.
Metabolites χ ± S | Group A (n = 31) | Group B (n = 9) | Group C (n = 13) | ||||||
|
|
|
|||||||
IS | MI | P-value | IS | MI | P-value | IS | MI | P-value | |
NAA/Cr | 1.09 ± 0.22 | 1.67 ± 0.36 | 0.007** | 0.91 ± 0.14 | 1.16 ± 0.24 | 0.038* | 0.87 ± 0.21 | 1.16 ± 0.26 | 0.029* |
Cho/Cr | 0.87 ± 0.19 | 1.04 ± 0.38 | 0.039* | 0.79 ± 0.21 | 1.07 ± 0.41 | 0.036* | 0.74 ± 0.19 | 1.3 ± 0.40 | 0.030* |
Lac/Cr | 0.35 ± 0.10 | 0 | / | 0.38 ± 0.13 | 0 | / | 0.49 ± 0.12 | 0 | / |
Group A, Good glycemic control group, HbAlc < 6.5%; Group B: Satisfactory glycemic control group, HbAlc: 6.5% 7.5%; Group C, Poor glycemic control group, HbAlc > 7.5%; IS: Infarcted area side; MI, Mirror of infarcted area; NAA, N-acetyl aspartate; Cr, Creatine; Cho, Choline; Lac, Lactate.
*P < 0.05, **P < 0.01.